Ziraoui, N.-E., Salazar, M., & Kensington, A. (2026). BCLC™ NAD⁺ Supplement System Targeting SIRT1: A Time-Sequential Biphasic NMN-Resveratrol-Quercetin Formulation with Supporting Clinical and Pharmacological Evidence. International Journal of Public Health and Medical Research, 6(4), 36-44. https://doi.org/10.62051/ijphmr.v6n4.06